DoseSpot Acquires Bravado Health’s ePrescribing Platform TreatRx to Expand Solution Set for Healthcare Providers
Summary
DEDHAM, Mass.--(BUSINESS WIRE)--DoseSpot, a software-as-a-service (SaaS) platform that enables clinicians to electronically write and transmit prescriptions to pharmacies, has acquired the TreatRx segment of Bravado Health to strengthen and expand DoseSpots solution set for healthcare providers and help advance its position in the ePrescribing software integration market. Bravado Healths existing ePrescribing customers will be supported throughout the transition, with no disruption to service, and will benefit from the added resources and capabilities of DoseSpot. "Together, TreatRx and DoseSpot will offer an enhanced, comprehensive solution to healthcare providers that will help them better serve patient needs,” added Bill Skarinka, Managing Director at PSG. Treat allows for providers workflow to be streamlined and made more convenient, working in real-time without requiring an EHR with either its stand-alone web offering or an integrated API connection. Having backed more than 120 companies and facilitated over 430 add-on acquisitions, PSG brings extensive investment experience, deep expertise in software and technology, and a firm commitment to collaborating with management teams.
Classifications
AskAI Classifications
LabelsLinked Companies
